TY - JOUR AU - Chan, D. C. AU - Fass, D. AU - Berger, J. M. PY - 1997 DA - 1997// TI - Core structure of gp41 from the HIV envelope glycoprotein JO - Cell VL - 89 UR - https://doi.org/10.1016/S0092-8674(00)80205-6 DO - 10.1016/S0092-8674(00)80205-6 ID - Chan1997 ER - TY - JOUR AU - Pantophlet, R. AU - Burton, D. R. PY - 2006 DA - 2006// TI - GP120: target for neutralizing HIV-1 antibodies JO - Annu Rev Immunol VL - 24 UR - https://doi.org/10.1146/annurev.immunol.24.021605.090557 DO - 10.1146/annurev.immunol.24.021605.090557 ID - Pantophlet2006 ER - TY - JOUR AU - Montero, M. AU - van Houten, N. E. AU - Wang, X. PY - 2008 DA - 2008// TI - The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design JO - Microbiol Mol Biol Rev VL - 72 UR - https://doi.org/10.1128/MMBR.00020-07 DO - 10.1128/MMBR.00020-07 ID - Montero2008 ER - TY - JOUR AU - Mascola, J. R. AU - Montefiori, D. C. PY - 2010 DA - 2010// TI - The role of antibodies in HIV vaccines JO - Annu Rev Immunol VL - 28 UR - https://doi.org/10.1146/annurev-immunol-030409-101256 DO - 10.1146/annurev-immunol-030409-101256 ID - Mascola2010 ER - TY - JOUR AU - Dalgleish, A. G. AU - Beverley, P. C. AU - Clapham, P. R. PY - 1984 DA - 1984// TI - The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus JO - Nature VL - 312 UR - https://doi.org/10.1038/312763a0 DO - 10.1038/312763a0 ID - Dalgleish1984 ER - TY - JOUR AU - Deng, H. AU - Liu, R. AU - Ellmeier, W. PY - 1996 DA - 1996// TI - Identification of a major co-receptor for primary isolates of HIV-1 JO - Nature VL - 381 UR - https://doi.org/10.1038/381661a0 DO - 10.1038/381661a0 ID - Deng1996 ER - TY - JOUR AU - Wyatt, R. AU - Kwong, P. D. AU - Desjardins, E. PY - 1998 DA - 1998// TI - The antigenic structure of the HIV gp120 envelope glycoprotein JO - Nature VL - 393 UR - https://doi.org/10.1038/31514 DO - 10.1038/31514 ID - Wyatt1998 ER - TY - JOUR AU - Zolla-Pazner, S. PY - 2004 DA - 2004// TI - Identifying epitopes of HIV-1 that induce protective antibodies JO - Nat Rev Immunol VL - 4 UR - https://doi.org/10.1038/nri1307 DO - 10.1038/nri1307 ID - Zolla-Pazner2004 ER - TY - JOUR AU - Walker, L. M. AU - Phogat, S. K. AU - Chan-Hui, P. -. Y. PY - 2009 DA - 2009// TI - Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target JO - Science VL - 326 UR - https://doi.org/10.1126/science.1178746 DO - 10.1126/science.1178746 ID - Walker2009 ER - TY - JOUR AU - Zhou, T. AU - Georgiev, I. AU - Wu, X. PY - 2010 DA - 2010// TI - Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 JO - Science VL - 329 UR - https://doi.org/10.1126/science.1192819 DO - 10.1126/science.1192819 ID - Zhou2010 ER - TY - JOUR AU - Lynch, R. M. AU - Shen, T. AU - Gnanakaran, S. PY - 2009 DA - 2009// TI - Appreciating HIV type 1 diversity: subtype differences in Env JO - AIDS Res Hum Retroviruses VL - 25 UR - https://doi.org/10.1089/aid.2008.0219 DO - 10.1089/aid.2008.0219 ID - Lynch2009 ER - TY - JOUR AU - Stamatos, N. M. AU - Mascola, J. R. AU - Kalyanaraman, V. S. PY - 1998 DA - 1998// TI - Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140 JO - J Virol VL - 72 ID - Stamatos1998 ER - TY - JOUR AU - Li, Y. AU - Migueles, S. A. AU - Welcher, B. PY - 2007 DA - 2007// TI - Broad HIV-1 neutralization mediated by CD4-binding site antibodies JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1624 DO - 10.1038/nm1624 ID - Li2007 ER - TY - JOUR AU - Walker, L. M. AU - Simek, M. D. AU - Priddy, F. PY - 2010 DA - 2010// TI - A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals JO - PLoS Pathog VL - 6 UR - https://doi.org/10.1371/journal.ppat.1001028 DO - 10.1371/journal.ppat.1001028 ID - Walker2010 ER - TY - JOUR AU - Binley, J. M. AU - Wrin, T. AU - Korber, B. PY - 2004 DA - 2004// TI - Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.23.13232-13252.2004 DO - 10.1128/JVI.78.23.13232-13252.2004 ID - Binley2004 ER - TY - JOUR AU - Wu, X. AU - Yang, Z. -. Y. AU - Li, Y. PY - 2010 DA - 2010// TI - Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 JO - Science VL - 329 UR - https://doi.org/10.1126/science.1187659 DO - 10.1126/science.1187659 ID - Wu2010 ER - TY - JOUR AU - Pejchal, R. AU - Doores, K. J. AU - Walker, L. M. PY - 2011 DA - 2011// TI - A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield JO - Science VL - 334 UR - https://doi.org/10.1126/science.1213256 DO - 10.1126/science.1213256 ID - Pejchal2011 ER - TY - JOUR AU - Gorny, M. K. AU - VanCott, T. C. AU - Hioe, C. PY - 1997 DA - 1997// TI - Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity JO - J Immunol VL - 159 ID - Gorny1997 ER - TY - JOUR AU - Gorny, M. K. AU - Williams, C. AU - Volsky, B. PY - 2006 DA - 2006// TI - Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1 JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.02202-05 DO - 10.1128/JVI.02202-05 ID - Gorny2006 ER - TY - JOUR AU - Stanfield, R. L. AU - Gorny, M. K. AU - Williams, C. PY - 2004 DA - 2004// TI - Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D JO - Structure VL - 12 UR - https://doi.org/10.1016/j.str.2004.01.003 DO - 10.1016/j.str.2004.01.003 ID - Stanfield2004 ER - TY - JOUR AU - Hioe, C. E. AU - Wrin, T. AU - Seaman, M. S. PY - 2010 DA - 2010// TI - Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0010254 DO - 10.1371/journal.pone.0010254 ID - Hioe2010 ER - TY - JOUR AU - Scheid, J. F. AU - Mouquet, H. AU - Ueberheide, B. PY - 2011 DA - 2011// TI - Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding JO - Science VL - 333 UR - https://doi.org/10.1126/science.1207227 DO - 10.1126/science.1207227 ID - Scheid2011 ER - TY - JOUR AU - Kwong, P. D. AU - Wyatt, R. AU - Robinson, J. PY - 1998 DA - 1998// TI - Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody JO - Nature VL - 393 UR - https://doi.org/10.1038/31405 DO - 10.1038/31405 ID - Kwong1998 ER - TY - JOUR AU - Huang, C. AU - Tang, M. AU - Zhang, M. -. Y. PY - 2005 DA - 2005// TI - Structure of a V3-containing HIV-1 gp120 core JO - Science VL - 310 UR - https://doi.org/10.1126/science.1118398 DO - 10.1126/science.1118398 ID - Huang2005 ER - TY - JOUR AU - Boudet, F. AU - Girard, M. AU - Theze, J. PY - 1992 DA - 1992// TI - Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120 JO - Int Immunol VL - 4 UR - https://doi.org/10.1093/intimm/4.2.283 DO - 10.1093/intimm/4.2.283 ID - Boudet1992 ER - TY - JOUR AU - Vogel, T. AU - Kurth, R. AU - Norley, S. PY - 1994 DA - 1994// TI - The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides JO - J Immunol VL - 153 ID - Vogel1994 ER - TY - JOUR AU - Fenouillet, E. AU - Blanes, N. AU - Benjouad, A. PY - 1995 DA - 1995// TI - Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity JO - Clin Exp Immunol VL - 99 UR - https://doi.org/10.1111/j.1365-2249.1995.tb05567.x DO - 10.1111/j.1365-2249.1995.tb05567.x ID - Fenouillet1995 ER - TY - JOUR AU - Andrabi, R. AU - Choudhary, A. K. AU - Bala, M. PY - 2011 DA - 2011// TI - Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence JO - Arch Virol VL - 156 UR - https://doi.org/10.1007/s00705-011-1053-5 DO - 10.1007/s00705-011-1053-5 ID - Andrabi2011 ER - TY - JOUR AU - Javaherian, K. AU - Langlois, A. J. AU - McDanal, C. PY - 1989 DA - 1989// TI - Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein JO - Proc Natl Acad Sci USA VL - 86 UR - https://doi.org/10.1073/pnas.86.17.6768 DO - 10.1073/pnas.86.17.6768 ID - Javaherian1989 ER - TY - JOUR AU - Goudsmit, J. AU - Debouck, C. AU - Meloen, R. H. PY - 1988 DA - 1988// TI - Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees JO - Proc Natl Acad Sci USA VL - 85 UR - https://doi.org/10.1073/pnas.85.12.4478 DO - 10.1073/pnas.85.12.4478 ID - Goudsmit1988 ER - TY - JOUR AU - Palker, T. J. AU - Clark, M. E. AU - Langlois, A. J. PY - 1988 DA - 1988// TI - Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides JO - Proc Natl Acad Sci USA VL - 85 UR - https://doi.org/10.1073/pnas.85.6.1932 DO - 10.1073/pnas.85.6.1932 ID - Palker1988 ER - TY - JOUR AU - Korber, B. T. AU - MacInnes, K. AU - Smith, R. F. PY - 1994 DA - 1994// TI - Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1 JO - J Virol VL - 68 ID - Korber1994 ER - TY - JOUR AU - Gaschen, B. AU - Taylor, J. AU - Yusim, K. PY - 2002 DA - 2002// TI - Diversity considerations in HIV-1 vaccine selection JO - Science VL - 296 UR - https://doi.org/10.1126/science.1070441 DO - 10.1126/science.1070441 ID - Gaschen2002 ER - TY - JOUR AU - Shioda, T. AU - Levy, J. A. AU - Cheng-Mayer, C. PY - 1992 DA - 1992// TI - Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1 JO - Proc Natl Acad Sci USA VL - 89 UR - https://doi.org/10.1073/pnas.89.20.9434 DO - 10.1073/pnas.89.20.9434 ID - Shioda1992 ER - TY - JOUR AU - Cardozo, T. AU - Kimura, T. AU - Philpott, S. PY - 2007 DA - 2007// TI - Structural basis for coreceptor selectivity by the HIV type 1 V3 loop JO - AIDS Res Hum Retroviruses VL - 23 UR - https://doi.org/10.1089/aid.2006.0130 DO - 10.1089/aid.2006.0130 ID - Cardozo2007 ER - TY - JOUR AU - Gorny, M. K. AU - Revesz, K. AU - Williams, C. PY - 2004 DA - 2004// TI - The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.5.2394-2404.2004 DO - 10.1128/JVI.78.5.2394-2404.2004 ID - Gorny2004 ER - TY - JOUR AU - Almond, D. AU - Kimura, T. AU - Kong, X. PY - 2010 DA - 2010// TI - Structural conservation predominates over sequence variability in the crown of HIV type 1’s V3 loop JO - AIDS Res Hum Retroviruses VL - 26 UR - https://doi.org/10.1089/aid.2009.0254 DO - 10.1089/aid.2009.0254 ID - Almond2010 ER - TY - JOUR AU - Jiang, X. AU - Burke, V. AU - Totrov, M. PY - 2010 DA - 2010// TI - Conserved structural elements in the V3 crown of HIV-1 gp120 JO - Nat Struct Mol Biol VL - 17 UR - https://doi.org/10.1038/nsmb.1861 DO - 10.1038/nsmb.1861 ID - Jiang2010 ER - TY - JOUR AU - Krachmarov, C. AU - Pinter, A. AU - Honnen, W. J. PY - 2005 DA - 2005// TI - Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking JO - J Virol VL - 79 UR - https://doi.org/10.1128/JVI.79.2.780-790.2005 DO - 10.1128/JVI.79.2.780-790.2005 ID - Krachmarov2005 ER - TY - JOUR AU - Zolla-Pazner, S. AU - Zhong, P. AU - Revesz, K. PY - 2004 DA - 2004// TI - The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1 JO - AIDS Res Hum Retroviruses VL - 20 UR - https://doi.org/10.1089/aid.2004.20.1254 DO - 10.1089/aid.2004.20.1254 ID - Zolla-Pazner2004 ER - TY - JOUR AU - Zolla-Pazner, S. AU - Kong, X. -. P. AU - Jiang, X. PY - 2011 DA - 2011// TI - Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA JO - J Virol VL - 85 UR - https://doi.org/10.1128/JVI.05086-11 DO - 10.1128/JVI.05086-11 ID - Zolla-Pazner2011 ER - TY - JOUR AU - Hemelaar, J. AU - Gouws, E. AU - Ghys, P. D. PY - 2006 DA - 2006// TI - Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 JO - AIDS VL - 20 UR - https://doi.org/10.1097/01.aids.0000247564.73009.bc DO - 10.1097/01.aids.0000247564.73009.bc ID - Hemelaar2006 ER - TY - JOUR AU - Nyambi, P. N. AU - Mbah, H. A. AU - Burda, S. PY - 2000 DA - 2000// TI - Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M JO - J Virol VL - 74 UR - https://doi.org/10.1128/JVI.74.15.7096-7107.2000 DO - 10.1128/JVI.74.15.7096-7107.2000 ID - Nyambi2000 ER - TY - JOUR AU - Nyambi, P. N. AU - Burda, S. AU - Bastiani, L. PY - 2001 DA - 2001// TI - A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1 JO - J Immunol Methods VL - 253 UR - https://doi.org/10.1016/S0022-1759(01)00384-2 DO - 10.1016/S0022-1759(01)00384-2 ID - Nyambi2001 ER - TY - JOUR AU - Mascola, J. R. AU - Louder, M. K. AU - Winter, C. PY - 2002 DA - 2002// TI - Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells JO - J Virol VL - 76 UR - https://doi.org/10.1128/JVI.76.10.4810-4821.2002 DO - 10.1128/JVI.76.10.4810-4821.2002 ID - Mascola2002 ER - TY - JOUR AU - Pinter, A. AU - Honnen, W. J. AU - He, Y. PY - 2004 DA - 2004// TI - The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.10.5205-5215.2004 DO - 10.1128/JVI.78.10.5205-5215.2004 ID - Pinter2004 ER - TY - JOUR AU - Gorny, M. K. AU - Williams, C. AU - Volsky, B. PY - 2002 DA - 2002// TI - Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades JO - J Virol VL - 76 UR - https://doi.org/10.1128/JVI.76.18.9035-9045.2002 DO - 10.1128/JVI.76.18.9035-9045.2002 ID - Gorny2002 ER - TY - JOUR AU - Zolla-Pazner, S. AU - Cohen, S. AU - Pinter, A. PY - 2009 DA - 2009// TI - Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope JO - Virology VL - 392 UR - https://doi.org/10.1016/j.virol.2009.05.039 DO - 10.1016/j.virol.2009.05.039 ID - Zolla-Pazner2009 ER - TY - JOUR AU - Moseri, A. AU - Tantry, S. AU - Sagi, Y. PY - 2010 DA - 2010// TI - An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120 JO - Virology VL - 401 UR - https://doi.org/10.1016/j.virol.2010.03.007 DO - 10.1016/j.virol.2010.03.007 ID - Moseri2010 ER - TY - JOUR AU - Gorny, M. K. AU - Gianakakos, V. AU - Sharpe, S. PY - 1989 DA - 1989// TI - Generation of human monoclonal antibodies to human immunodeficiency virus JO - Proc Natl Acad Sci USA VL - 86 UR - https://doi.org/10.1073/pnas.86.5.1624 DO - 10.1073/pnas.86.5.1624 ID - Gorny1989 ER - TY - JOUR AU - Malaspina, A. AU - Moir, S. AU - Kottilil, S. PY - 2003 DA - 2003// TI - Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function JO - J Immunol VL - 170 UR - https://doi.org/10.4049/jimmunol.170.12.5965 DO - 10.4049/jimmunol.170.12.5965 ID - Malaspina2003 ER - TY - JOUR AU - Birx, D. L. AU - Redfield, R. R. AU - Tosato, G. PY - 1986 DA - 1986// TI - Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders JO - N Engl J Med VL - 314 UR - https://doi.org/10.1056/NEJM198604033141403 DO - 10.1056/NEJM198604033141403 ID - Birx1986 ER - TY - JOUR AU - Yarchoan, R. AU - Redfield, R. R. AU - Broder, S. PY - 1986 DA - 1986// TI - Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus JO - J Clin Invest VL - 78 UR - https://doi.org/10.1172/JCI112595 DO - 10.1172/JCI112595 ID - Yarchoan1986 ER - TY - JOUR AU - Felsövályi, K. AU - Nádas, A. AU - Zolla-Pazner, S. PY - 2006 DA - 2006// TI - Distinct sequence patterns characterize the V3 region of HIV type 1 gp120 from subtypes A and C JO - AIDS Res Hum Retroviruses VL - 22 UR - https://doi.org/10.1089/aid.2006.22.703 DO - 10.1089/aid.2006.22.703 ID - Felsövályi2006 ER - TY - JOUR AU - Patel, M. B. AU - Hoffman, N. G. AU - Swanstrom, R. PY - 2008 DA - 2008// TI - Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins JO - J Virol VL - 82 UR - https://doi.org/10.1128/JVI.01444-07 DO - 10.1128/JVI.01444-07 ID - Patel2008 ER - TY - JOUR AU - Zwart, G. AU - Langedijk, H. AU - van der Hoek, L. PY - 1991 DA - 1991// TI - Immunodominance and antigenic variation of the principal neutralization domain of HIV-1 JO - Virology VL - 181 UR - https://doi.org/10.1016/0042-6822(91)90880-K DO - 10.1016/0042-6822(91)90880-K ID - Zwart1991 ER - TY - JOUR AU - Stanfield, R. L. AU - Gorny, M. K. AU - Zolla-Pazner, S. PY - 2006 DA - 2006// TI - Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.00205-06 DO - 10.1128/JVI.00205-06 ID - Stanfield2006 ER - TY - JOUR AU - Bell, C. H. AU - Pantophlet, R. AU - Schiefner, A. PY - 2008 DA - 2008// TI - Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization JO - J Mol Biol VL - 375 UR - https://doi.org/10.1016/j.jmb.2007.11.013 DO - 10.1016/j.jmb.2007.11.013 ID - Bell2008 ER - TY - JOUR AU - Gorny, M. K. AU - Wang, X. -. H. AU - Williams, C. PY - 2009 DA - 2009// TI - Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1 JO - Mol Immunol VL - 46 UR - https://doi.org/10.1016/j.molimm.2008.09.005 DO - 10.1016/j.molimm.2008.09.005 ID - Gorny2009 ER - TY - JOUR AU - Gorny, M. K. AU - Sampson, J. AU - Li, H. PY - 2011 DA - 2011// TI - Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027780 DO - 10.1371/journal.pone.0027780 ID - Gorny2011 ER - TY - JOUR AU - Wei, X. AU - Decker, J. M. AU - Wang, S. PY - 2003 DA - 2003// TI - Antibody neutralization and escape by HIV-1 JO - Nature VL - 422 UR - https://doi.org/10.1038/nature01470 DO - 10.1038/nature01470 ID - Wei2003 ER - TY - JOUR AU - Davis, K. L. AU - Gray, E. S. AU - Moore, P. L. PY - 2009 DA - 2009// TI - High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination JO - Virology VL - 387 UR - https://doi.org/10.1016/j.virol.2009.02.022 DO - 10.1016/j.virol.2009.02.022 ID - Davis2009 ER - TY - JOUR AU - Totrov, M. AU - Jiang, X. AU - Kong, X. -. P. PY - 2010 DA - 2010// TI - Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold JO - Virology VL - 405 UR - https://doi.org/10.1016/j.virol.2010.06.027 DO - 10.1016/j.virol.2010.06.027 ID - Totrov2010 ER - TY - JOUR AU - Tripathy, S. AU - Renjifo, B. AU - Wang, W. K. PY - 1996 DA - 1996// TI - Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India JO - AIDS Res Hum Retroviruses VL - 12 UR - https://doi.org/10.1089/aid.1996.12.1199 DO - 10.1089/aid.1996.12.1199 ID - Tripathy1996 ER - TY - JOUR AU - Maitra, A. AU - Singh, B. AU - Banu, S. PY - 1999 DA - 1999// TI - Subtypes of HIV type 1 circulating in India: partial envelope sequences JO - AIDS Res Hum Retroviruses VL - 15 UR - https://doi.org/10.1089/088922299310656 DO - 10.1089/088922299310656 ID - Maitra1999 ER - TY - JOUR AU - Gorny, M. K. AU - Xu, J. Y. AU - Gianakakos, V. PY - 1991 DA - 1991// TI - Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein JO - Proc Natl Acad Sci USA VL - 88 UR - https://doi.org/10.1073/pnas.88.8.3238 DO - 10.1073/pnas.88.8.3238 ID - Gorny1991 ER - TY - JOUR AU - Traggiai, E. AU - Becker, S. AU - Subbarao, K. PY - 2004 DA - 2004// TI - An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1080 DO - 10.1038/nm1080 ID - Traggiai2004 ER - TY - JOUR AU - Gigler, A. AU - Dorsch, S. AU - Hemauer, A. PY - 1999 DA - 1999// TI - Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins JO - J Virol VL - 73 ID - Gigler1999 ER - TY - JOUR AU - Marks, J. D. AU - Tristem, M. AU - Karpas, A. PY - 1991 DA - 1991// TI - Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes JO - Eur J Immunol VL - 21 UR - https://doi.org/10.1002/eji.1830210419 DO - 10.1002/eji.1830210419 ID - Marks1991 ER - TY - JOUR AU - Gorny, M. K. AU - VanCott, T. C. AU - Williams, C. PY - 2000 DA - 2000// TI - Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins JO - Virology VL - 267 UR - https://doi.org/10.1006/viro.1999.0095 DO - 10.1006/viro.1999.0095 ID - Gorny2000 ER - TY - JOUR AU - Nyambi, P. N. AU - Gorny, M. K. AU - Bastiani, L. PY - 1998 DA - 1998// TI - Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1 JO - J Virol VL - 72 ID - Nyambi1998 ER - TY - JOUR AU - Li, M. AU - Gao, F. AU - John, R. PY - 2005 DA - 2005// TI - Mascola, et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies JO - J Virol VL - 79 UR - https://doi.org/10.1128/JVI.79.16.10108-10125.2005 DO - 10.1128/JVI.79.16.10108-10125.2005 ID - Li2005 ER - TY - JOUR AU - Seaman, M. S. AU - Janes, H. AU - Hawkins, N. PY - 2010 DA - 2010// TI - Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies JO - J Virol VL - 84 UR - https://doi.org/10.1128/JVI.02108-09 DO - 10.1128/JVI.02108-09 ID - Seaman2010 ER -